All News

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Don’t waste time digging through articles to find the most up-to-date and important news. Drug Topics® has you covered with our weekly news roundup of the latest pharmacy-related news you should know before the weekend begins. Here’s a roundup of the latest news coverage from Drug Topics®.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Here’s a roundup of the latest news coverage from Drug Topics®.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Here’s a roundup of the latest news coverage from Drug Topics®.

The consumer products giant voluntarily recalled 4 NEUTROGENA® and 1 AVEENO® spray sunscreen products July 14 after internal testing found low levels of benzene, a carcinogen, in some product samples.

Johnson & Johnson released a statement providing more information on the risks and benefits of its single-shot COVID-19 vaccine.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Here’s a roundup of the latest news coverage from Drug Topics®.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Here’s a roundup of the latest news coverage from Drug Topics®.

Texas-based pharmacy is one of three nationwide up for the award.

Iowa-based pharmacy is one of three nationwide up for the award.

California-based pharmacy is one of three nationwide up for the award

Here’s a roundup of the latest news coverage from Drug Topics®.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Although COVID-19 remains a real threat, it seems we are now progressing toward a return to normalcy thanks to the widespread availability of vaccines and tireless efforts of our health care workers.

Here’s a roundup of the latest news coverage from Drug Topics®.

The RECOVERY study demonstrated that an antibody combination therapy (REGEN-COV; Regeneron) improved survival in hospitalized patients, a first for COVID-19 antibody treatments.

Novavax’s recombinant nanoparticle protein-based COVID-19 vaccine showed an overall efficacy of 90.4% and 100% efficacy against moderate and severe disease.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Here’s a roundup of the latest coronavirus-related news.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Addressing the needs of LGBTQ+ patients requires insight, innovation, and introspection.

The antibody combination COVID-19 treatment is the only one of its kind available in the United States.

Aducanumab (Aduhelm; Biogen) is the first approved novel treatment for Alzheimer disease since 2003.

Here’s a roundup of the latest coronavirus-related news.

AmerisourceBergen Corporation today announced the completion of its acquisition of the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses.

Moderna has initiated the rolling submission process for the biologics license application for its COVID-19 vaccine mRNA-1273.